Advisor Group Holdings, Inc. Acurx Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

$67.1 Billion
Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 7,582 shares of ACXP stock, worth $31,996. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,582

Previous 10,452 27.46%

Holding current value

$31,996

Previous $5,000 540.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$0.29 - $5.31 $832 - $15,239	-2,870 Reduced 27.46%	7,582 $32,000
Q2 2025 Sep 04, 2025	SELL	$0.3 - $0.82 $104 - $285	-348 Reduced 3.22%	10,452 $5,000
Q2 2025 Aug 13, 2025	BUY	$0.3 - $0.82 $365 - $998	1,218 Added 12.71%	10,800 $5,000
Q1 2025 May 12, 2025	SELL	$0.39 - $1.09 $1,791 - $5,006	-4,593 Reduced 32.4%	9,582 $3,000
Q4 2024 Jun 06, 2025	BUY	$0.72 - $2.15 $1,542 - $4,607	2,143 Added 22.36%	11,725 $9,000
Q4 2024 Feb 07, 2025	SELL	$0.72 - $2.15 $25 - $75	-35 Reduced 0.25%	14,175 $11,000
Q3 2024 Nov 13, 2024	SELL	$1.83 - $2.62 $1,830 - $2,620	-1,000 Reduced 6.57%	14,210 $26,000
Q2 2024 Aug 13, 2024	SELL	$1.64 - $2.79 $68,945 - $117,291	-42,040 Reduced 73.43%	15,210 $34,000
Q4 2023 Feb 12, 2024	BUY	$1.28 - $5.76 $40,000 - $180,000	31,250 Added 120.19%	57,250 $219,000
Q3 2023 Nov 13, 2023	BUY	$1.41 - $2.55 $5,640 - $10,200	4,000 Added 18.18%	26,000 $39,000
Q2 2023 Aug 10, 2023	BUY	$2.47 - $3.53 $14,820 - $21,180	6,000 Added 37.5%	22,000 $58,000
Q1 2023 May 12, 2023	BUY	$3.06 - $4.5 $12,240 - $18,000	4,000 Added 33.33%	16,000 $55,000
Q3 2022 Nov 14, 2022	BUY	$3.0 - $4.78 $3,000 - $4,780	1,000 Added 9.09%	12,000 $36,000
Q2 2022 Aug 10, 2022	BUY	$2.42 - $4.0 $26,620 - $44,000	11,000 New	11,000 $42,000
Q1 2022 May 04, 2022	SELL	$3.11 - $4.74 $9,330 - $14,220	-3,000 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$3.77 - $6.18 $11,310 - $18,540	3,000 New	3,000 $15,000

Others Institutions Holding ACXP

# of Institutions

Shares Held

36.4K

Call Options Held

100

Put Options Held

View Full List

About Acurx Pharmaceuticals, Inc.

Ticker ACXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,556,600
Market Cap $48.8M
Description
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...

More about ACXP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Acurx Pharmaceuticals, Inc. Transaction History